Close

Envigo appoints Lynn Lewis as Senior Vice President of Global Sales

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

Envigo, a leading provider of nonclinical contract research services and research models, announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales.

She brings extensive knowledge in both science and business to the company through her successful career in pharmaceuticals and leadership roles within sales and operations in the contract research organization (CRO) industry. This new role was created to strengthen the company’s position in the marketplace with a focus on continuing to provide outstanding customer service. Lynn will report to Craig Boyd, Envigo’s Chief Commercial Officer.

“Given the dynamic growth in the CRO industry, there is an increasing opportunity to further engage our existing customers, as well as attract emerging life sciences companies to Envigo’s extensive non-clinical service offerings and research products. We are thrilled that Lynn Lewis has joined our team to drive this important effort,” said Dr. Adrian Hardy, President and Chief Executive Officer. 

“Lynn’s broad experience leading billion dollar, successful global sales organizations serving the biopharmaceutical industry will be an invaluable asset to our commercial team. Under her guidance, our sales teams in North America, Europe and Asia Pacific will be unified which will provide additional focus on enterprise-wide growth initiatives and an enhanced customer experience, while contributing to our vision to work together to build a healthier and safer world.”

Prior to joining Envigo, Lynn was most recently Group Vice President of Business Development, Clinical Development and Commercialization Services for Covance. During her 15 year career with Covance, she also led the global sales organizations for Covance’s nonclinical and central laboratory businesses and also served as the General Manager of Covance’s drug discovery and development campus in Greenfield, Indiana. Before joining Covance, Lynn worked for Eli Lilly and Company leading cross functional development teams to bring new medicines to market. She holds a Master of Business Administration from University of North Carolina at Chapel Hill and a Bachelor of Science degree in Biology from Bucknell University.

About Envigo
Envigo provides mission-critical products and research services for pharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. The Company is founded on the principle that research partnerships depend on unmatched expertise, unwavering dedication to customer service, and shared goals. Envigo is committed to helping customers realize the full potential of their products and research which contribute to enhancing the lives of people and animals as well as protecting the environment. With over 3,300 employees worldwide, Envigo provides comprehensive scientific expertise and a full service offering in non-clinical research and development, research models and services, regulatory consulting, and analytical support to customers. Envigo’s corporate headquarters are located in New Jersey. ( www.envigo.com)

Latest stories